Endogenous p53 gene status predicts the response of human squamous cell carcinomas to wild-type p53

Cancer Gene Therapy

Volumn 7, Issue 5, 2000, Pages 749-756

  St John, Lisa S ^a,b   Sauter, Edward R ^c   Herlyn, Meenhard ^c   Litwin, Samuel ^d   Adler Storthz, Karen ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c WISTAR INSTITUTE   (United States)

^d FOX CHASE CANCER CENTER   (United States)

Author keywords

Apoptosis; Growth arrest; P21; P53; Squamous cell carcinoma; WAF1

Indexed keywords

PROTEIN P53; VIRUS VECTOR;

ADENOVIRUS; APOPTOSIS; ARTICLE; CELL CYCLE; COMBINED IMMUNODEFICIENCY; GENE THERAPY; GROWTH INHIBITION; HUMAN; HUMAN CELL; KERATINOCYTE; POINT MUTATION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; WART VIRUS;

ADENOVIRIDAE; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS;

EID: 0034106051     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700166     Document Type: Article

References (33)

1. Hollstein M, Sidransky D, Vogelstein B, Harris CC. P53 mutations in human cancers. Science. 1991;253:49-53.
2. Boyle JO, Hakim J, Koch W, et al. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res. 1993;53:4477-4480.
3. Watling DL, Gown AM, Coltera MD. Overexpression of p53 in head and neck cancer. Head Neck. 1992;14:437-444.
4. Baker SJ, Markowitz S, Fearon ER, Willson JKV, Vogelstein B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science. 1990;249:912-915.
5. Chen PL, Chen Y, Bookstein R, Lee WH. Genetic mechanisms of tumor suppression by the human p53 gene. Science. 1990;250:1576-1580.
6. Isaacs WB, Carter BS, Ewing CM. Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles. Cancer Res. 1991;51:4716-4720.
7. Liu TJ, Zhang WW, Taylor DL, et al. Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus. Cancer Res. 1994;54:3662-3667.
8. Yonish-Rouach E, Resnitzky D, Lotem J, et al. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature. 1991;352:345-347.
9. Mujoo K, Maneval DC, Anderson SC, Gutterman JU. Adenoviral-mediated p53 tumor suppressor gene therapy of human ovarian carcinoma. Oncogene. 1996;12:1617-1623.
10. Kock H, Harris MP, Anderson SC, et al. Adenoviral-mediated p53 gene transfer suppresses growth of human glioblastoma cells in vitro and in vivo. Int J Cancer. 1996;67:808-815.
11. Yang C, Cirielli C, Capogrossi MC, Passaniti A. Adenoviral-mediated wild-type p53 expression induces apoptosis and suppresses tumorigencsis of prostatic tumor cells. Cancer Res. 1995;55:4210-4213.
12. Zhang WW, Fang X, Mazur W, et al. High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus. Cancer Gene Ther. 1994;1:5-13.
13. Hamada K, Alemany R, Zhang WW, et al. Adenoviral-mediated transfer of a wild-type p53 gene and induction of apoptosis in cervical cancer. Cancer Res. 1996;56:3047-3054.
14. Sakai E, Tsuchida N. Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor-suppressor genes. Oncogene. 1992;7:927-933.
15. Somers KD, Merrick MA, Lopez ME, et al. Frequent p53 mutations in head and neck cancer. Cancer Res. 1992;52: 5997-6000.
16. Yeudall WA. Human papillomaviruses and oral neoplasia. Eur J Cancer B Oral Oncol. 1992;28B:61-66.
17. Riou G, Favre M, Jeannel D, et al. Association between poor prognosis in early-stage invasive cervical carcinomas and non-detection of HPV DNA. Lancet. 1990;335:1171-1174.
18. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by the human papillomavirus types 16 and18 promotes the degradation of p53. Cell. 1990;63:1129-1136.
19. Scheffner M, Munger K, Byrne JC, Howley PM. The stage of p53 and the retinoblastoma genes in human cervical carcinoma cell lines. Proc Natl Acad Sci USA. 1991;88: 5523-5527.
20. Brachman DG, Graves D, Vokes E, et al. Occurrence of p53 gene deletions and human papillomavirus infection in human head and neck cancer. Cancer Res. 1992;52:4832-4836.
21. Riou G, Favre M, Jeanel D, Bourhis J, Le Doussal V, Orth G. Association between poor prognosis in early stage invasive cervical carcinoma and non-detection of HPV DNA. Lancet. 1990;355:1171-1174.
22. Higgins GD, Davy M, Rader D, Uzelin DM, Phillips GE, Burrell CJ. Increased age and mortality associated with cervical carcinomas negative for human papilloma virus RNA. Lancet. 1991;338:910-913.
23. Liu TJ, El-Naggar AK, McDonnell TJ, et al. Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck. Cancer Res. 1995;55:3117-3122.
24. Southgate J, Trejdosciewicz LK, Hodges GM. Primary culture of human oral epithelial cells: growth requirements and expression of differential characteristics. Lab Invest. 1987;56:211-223.
25. Overholt SM, Liu TJ, Taylor DL, et al. Head and neck squamous cell growth suppression using adenoviral-p53-FLAG: a potential marker for gene therapy trials. Clin Cancer Res. 1997;3:185-191.
26. El-Diery WS, Tokino T, Velculescu VE, et al. WAF1, a potential mediator of p53 tumor suppression. Cell. 1993; 75:817-825.
27. Gorczyca W, Gong J, Darzynkiewicz Z, et al. Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res. 1993;53:1945-1951.
28. Clayman GL, El-Naggar AK, Roth JA, et al. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. Cancer Res. 1995;55:1-6.
29. Clayman GL, El-Naggar AK, Lippman SM, et al. Adenoviral-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma. J Clin Oncol. 1998;16:2221-2232.
30. Finlay CA, Hinds PW, Levine AJ. The p53 proto-oncogene can act as a suppressor of transformation. Cell. 1989;57:1083-1093.
31. Wang TH, Wang HS. P53, apoptosis, and human cancers. J Formos Med Assoc. 1996;95:509-522.
32. Nguyen DM, Wiehle SA, Koch PE, et al. Delivery of the p53 tumor suppressor gene into lung cancer cells by an adenovirus/DNA complex. Cancer Gene Ther. 1997;4:191-198.
33. Nguyen DM, Spitz FR, Yen N, Cristiano RJ, Roth JA Gene therapy for lung cancer: enhancement of tumor suppression by a combination of sequential systemic cisplatin and adenovirus-mediated p53 gene transfer. J Thorac Cardiovasc Surg. 1996;112:1372-1376.